Abdul Moiz Siddiqi: Systematic Review Finds Comparable Outcomes for Ticagrelor and Prasugrel in ACS
Abdul Moiz Siddiqi, Bachelor of Medicine and Surgery at Dow Medical College, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cardiology in Review, adding:
“Alhumdulillah, I am incredibly thrilled to announce my first ever publication!
Our paper ‘Comparative Efficacy and Safety of Ticagrelor and Prasugrel in Acute Coronary Syndrome’ is now published in the ‘Cardiology in Review‘ journal.
Key Takeaways:
- Prasugrel and ticagrelor demonstrated comparable clinical efficacy and safety profiles in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI)
- All-cause mortality occurred in exactly 3.53 percent of patients in both treatment arms, showing zero statistical difference between the two drugs (P=0.66)
- No significant differences were observed across major secondary ischemic outcomes, including cardiovascular death, myocardial infarction, stent thrombosis or stroke
- There is no clear universal winner or drug hierarchy so clinicians should select the P2Y12 inhibitor based on specific patient traits, compliance factors (like once-daily versus twice-daily dosing), tolerability, and explicit contraindications
This is my first ever grand achievement in the field of medicine and research.
I am grateful to have worked alongside incredibly supportive, passionate and professional peers without whom this would not have been possible.
I am specially grateful to Muhammad Ahmed and Shaheer Bin Shafiq my mentors for believing in me and providing me the opportunity to work on this project.”
Title: Comparative Efficacy and Safety of Ticagrelor and Prasugrel in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials
Authors: Shafiq Shaheer Bin, Razzak, Muhammad Junaid Ahmed Muhammad, Khan Ghulam Taha, Siddiqi Abdul Moiz, Bilal Abdur Rafay, Tariq Mansoor Khubaib, Sohaib Asharib, Khan Muhammad Abdullah, Majid Mominah, Ahmed Taha, Abbasi Maham, Waqas Saad Ahmed
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 08:39Emily Bury: Putting Patients at the Centre of VTE Care
-
Oct 6, 2026, 07:44Carolina Moreira Ponce: Thrombosis Month – Why Prevention Starts With Risk Assessment
-
Oct 6, 2026, 07:03Laila Ahmed: Stroke Imaging – A Practical Radiology Approach
-
Oct 6, 2026, 05:52David Esposito: Can Standard Ultrasound Detect May Thurner Syndrome?
-
Oct 6, 2026, 04:33Hessam Kakavand: Rethinking Thrombotic Risk in Modern Cancer Therapy
-
Oct 6, 2026, 04:07Moussa Zein Aldine: Acute Coronary Syndrome Every Minute Matters
-
Oct 6, 2026, 03:13Patrick Taylor: Glow Stack Trend What the Evidence Really Shows
-
Oct 6, 2026, 02:59Preventing Hospital Associated Venous Thromboembolism – Thrombosis Canada
-
Oct 6, 2026, 02:42Treatment of Iron Deficiency With and Without Anemia – American Society of Hematology